FDA — authorised 14 June 1973
- Status: approved
🇺🇸 Sanorex in United States
FDA authorised Sanorex on 14 June 1973
Marketing authorisations
FDA — authorised 14 June 1973
- Application: NDA017247
- Marketing authorisation holder: NOVARTIS
- Local brand name: SANOREX
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 28 August 1980
- Application: NDA017980
- Marketing authorisation holder: WYETH AYERST
- Local brand name: MAZANOR
- Indication: TABLET — ORAL
- Status: approved
Sanorex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Sanorex approved in United States?
Yes. FDA authorised it on 14 June 1973; FDA authorised it on 14 June 1973; FDA authorised it on 28 August 1980.
Who is the marketing authorisation holder for Sanorex in United States?
Marketing authorisation holder not available in our data.